Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early high-dose methylprednisolone for acute leprous neuritis and type 1 leprosy reaction with neuritis
ISRCTN31894035Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in leprosy (HD) comparing Early IV methylprednisolone with Standard prednisolone plus placebo infusion (2 arms). Primary endpoint: Nerve function. Started Dec 2005; status: completed.
02
Drugs
methylprednisoloneprednisolone
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on ISRCTN31894035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31894035.